Login to your account

Username *
Password *
Remember Me

Blog With Right Sidebar

Randomized trial: Remdesivir vs. standard care in patients with moderate COVID-19

Remdesivir….good editorial, concludes we don't know who to give it to, nor for how long, nor if it improves outcomes, nor whether, if it does, it does that beyond what dexamethasone

or other corticosteroids do. https://t.co/Qi1dTSPcYi

— Dr. Tom Frieden (@DrTomFrieden) August 21, 2020

Search

Latest News